Follitrope (Follitropin alfa) Solution for Injection IM/SC

Follitrope (Follitropin alfa) is a synthetic follicle-stimulating hormone (FSH) injection designed to address infertility through targeted hormonal stimulation. This medication works by prompting ovarian follicle development in women undergoing fertility treatments, including ovulation induction and IVF cycles, while in men it supports sperm production when hormonal deficiencies are the underlying cause. Administration is via subcutaneous injection, typically into the abdomen, thigh, or upper arm. Treatment demands careful medical oversight with regular blood tests and ultrasound monitoring to track follicle progression, assess hormone levels, and minimize the risk of ovarian hyperstimulation syndrome and other complications. Users should expect potential side effects including mild headaches, abdominal discomfort, bloating, nausea, and localized injection site reactions such as pain, bruising, or swelling. Ovarian cyst formation may occur during treatment cycles. Follitrope requires a valid prescription and should only be used under the guidance of a reproductive endocrinologist or fertility specialist who can personalize dosing and monitor treatment response. Storage should follow manufacturer guidelines, and patients must report any unusual symptoms or concerns immediately to their healthcare provider. This medication represents a cornerstone therapy in modern assisted reproductive medicine, offering hope to individuals and couples navigating infertility challenges through evidence-based hormonal intervention.